Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer
2024 · Molecular Cancer · 36 citations
https://doi.org/10.1186/s12943-024-01945-9
W
Wenli Diao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
864
Citations
18
h-index
21
i10-index
Wenli Diao is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Ferroptosis and cancer prognosis & MicroRNA in disease regulation & RNA modifications and cancer. The author has an h-index of 18, co-authored 43 publications.
Papers by this author
worksCancer-associated fibroblasts promote the stemness and progression of renal cell carcinoma via exosomal miR-181d-5p
2022 · Cell Death Discovery · 31 citations
https://doi.org/10.1038/s41420-022-01219-7
Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers
2022 · Cancer Cell International · 24 citations
https://doi.org/10.1186/s12935-022-02467-4
Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence
2019 · BMC Urology · 20 citations
https://doi.org/10.1186/s12894-019-0530-0
SFXN1 promotes bladder cancer metastasis by restraining PINK1-dependent mitophagy
2025 · Oncogene · 3 citations
https://doi.org/10.1038/s41388-025-03460-7
HDAC2 as a therapeutic target in bladder cancer: insights into the altered epigenetic regulation and lysine lactylation
2025 · Journal of Experimental & Clinical Cancer Research · 1 citations
https://doi.org/10.1186/s13046-025-03610-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat